Skip to main content

Healthcare AI Readiness Assessment

Answer 7–8 questions in about 5 minutes and get an instant 0–100 AI readiness score with three next steps. The guide below the quiz explains what each area means for healthcare. Free, no signup to start.

Question 1 of 7–80% complete
Quick start

How many people work at your company?

What is a healthcare AI readiness assessment?

A healthcare AI readiness assessment checks whether a hospital, clinic or life-sciences organization has the prerequisites to run AI in production: clinical data that is usable and PHI-governed, EHR systems that can exchange data with an AI tool, people who own the clinical workflow, and a compliance posture that covers HIPAA, provincial health-privacy law and, where it applies, FDA rules for software as a medical device.

The quiz above gives you a 0–100 baseline in about 5 minutes. It does not replace a clinical-safety review, a privacy impact assessment or a regulatory pathway decision; it tells you which of those gaps to look at first.

In healthcare the cost of a wrong production deployment is measured in patient outcomes and regulatory findings, not just lost spend. That is why readiness here starts with data governance and clinical ownership, before any vendor demo.

Get your healthcare AI readiness score in about 5 minutes.

The quiz at the top of this page is the AIDOLS cross-industry assessment: 7–8 questions, about 5 minutes, an instant 0–100 score. The sections below explain what each area means for healthcare, the failure patterns to check for and the regulations that apply.

Why healthcare teams check AI readiness before they buy

Most clinical AI that stalls does not fail on the model. It fails on prerequisites: PHI that cannot legally be used for training, EHR integration that takes months longer than the vendor quoted, no clinical owner, or no decision on whether the tool is regulated as a medical device. A readiness check surfaces those prerequisites before capital is committed.

Regulators are also asking for documentation earlier. The FDA expects a predetermined change control plan for AI-enabled device software that will be updated after clearance, the EU AI Act treats AI in regulated medical devices as high-risk, and Canadian health-privacy law (PHIPA in Ontario, Law 25 in Quebec) sets its own rules for secondary use of health data.

Healthcare also has one area other industries can skip: clinical validation. A forecasting model in retail can ship at modest accuracy and still pay back; a clinical prediction model needs prospective validation at the deploying site before anyone acts on it.

Five areas that decide healthcare AI readiness

The quiz scores five general dimensions: strategy, data, tooling, team and governance. In healthcare, those dimensions come down to the five areas below. Read your score against them to see where your gaps are likely to be.

Clinical data quality and PHI governance

Whether your clinical data is structured, labeled, longitudinal and PHI-governed. Covers EHR data normalization (FHIR, HL7, OMOP CDM), imaging data (DICOM), claims data, and the de‑identification process used before any training.

Why this matters in healthcare:

Clinical AI is only as good as the data it learns from, and PHI rules decide which data you may use at all. Normalizing data across EHR vendors in a multi-site system is often the longest task in the whole project.

EHR and IT infrastructure

Whether your stack can run AI workloads without breaking clinical workflows. Covers the EHR API surface (FHIR R4, SMART on FHIR), integration engines, cloud or on‑premise compute that meets your security requirements, and uptime expectations for clinical systems.

Why this matters in healthcare:

Clinical AI has to appear inside the EHR workflow to be used. If your EHR cannot expose the data or accept a write-back, every vendor integration becomes a custom project.

Clinical talent and informatics capacity

Clinical-AI roles plus clinical informatics capacity across the organization. Covers CMIO or CHIO leadership, clinical informaticists, engineers with healthcare data experience, and AI literacy for the clinicians who will use the output.

Why this matters in healthcare:

Clinical workflow integration is a translation problem between data teams and frontline clinicians. Without informatics capacity, deployments stall between a working model and a used one.

Organizational and clinical change-readiness

Executive sponsorship, change capacity at the unit level, and clarity of clinical use cases. Covers CMO, CMIO and COO alignment, quality-committee engagement, and clinician-led pilot governance.

Why this matters in healthcare:

A clinical tool rolled out without nursing and physician buy-in gets worked around at shift change. This area predicts whether a deployment survives its first months of frontline use.

HIPAA, health-privacy and regulatory posture

Privacy, security, bias testing and regulatory readiness. Covers HIPAA Privacy and Security Rule controls, business associate agreements with every AI subprocessor, PIPEDA and PHIPA (Canada), Quebec Law 25, GDPR for EU patients, and FDA rules for software as a medical device.

Why this matters in healthcare:

This is the regulatory floor for production clinical AI. Gaps here block deployment regardless of how well the model performs, so they belong at the start of the plan, not the end.

5 failure patterns to check for in healthcare

These patterns derail healthcare AI deployments most often. Each is a prerequisite you can check before you buy; closing one is usually worth more than another vendor demo.

1. PHI leakage in training data

Pattern: Models trained on "de-identified" data that still carries re-identification risk: dates of service, rare diagnoses, small geographies, or free-text notes containing names.

What to check: Use a formal de‑identification method (HIPAA Safe Harbor or Expert Determination) before training, and a data-use agreement that names AI training explicitly. Check that both exist before a vendor touches the data.

2. No regulatory pathway decision

Pattern: Clinical-decision-support AI shipped without deciding whether it is regulated as a medical device, or without a plan for how the model will be updated after release.

What to check: Decide the regulatory pathway before deployment and, if the model will retrain in production, document a predetermined change control plan. Check who in your organization owns that decision.

3. Clinical-validation shortfalls

Pattern: Deploying clinical AI on retrospective accuracy alone, without validating it against your own patient population, EHR data and workflow. Models routinely perform worse at a new site than in the vendor’s test set.

What to check: Run a silent-mode validation period at the deploying site (the model runs but clinicians do not see it) and compare its output with ground truth before activation. Check that the protocol is written down.

4. EHR integration delays

Pattern: A vendor quotes a short integration that takes months because the deploying organization lacks FHIR endpoints, write-back permissions or integration-engine capacity.

What to check: Review integration readiness before procurement: FHIR endpoint availability, write-back permissions, EHR vendor relationships and integration-team capacity.

5. No clinical owner

Pattern: Clinical AI sponsored by IT or an innovation team with no named clinical owner. When frontline friction appears, nobody defends or fixes the deployment.

What to check: Name a clinical owner (CMO, CMIO, department chair or service-line medical director) with budget authority and a quality-committee mandate before procurement starts.

Healthcare AI regulations to map before production

Healthcare is one of the most regulated environments for AI. The frameworks below are the ones to map before production; which apply depends on where your patients and data are. AIDOLS works within each client’s HIPAA, PIPEDA or PHIPA regime; it does not certify compliance.

HIPAA + HITECH (US)

Privacy and Security Rule controls applied to AI training data and model output, a business associate agreement with every subprocessor (including model APIs and cloud inference), and breach-notification readiness that covers AI-specific exposure such as model-output leakage.

FDA software as a medical device (US)

A decision on whether the tool is a regulated device and, if it is, the right submission pathway. AI-enabled device software that will change after clearance needs a predetermined change control plan. The clinical-decision-support exemption is narrow; check it before assuming it applies.

EU AI Act + GDPR

AI in medical devices that require a notified-body conformity assessment is high-risk under the EU AI Act, with obligations for technical documentation, human oversight and post-market monitoring. GDPR Article 22 limits solely automated decisions about EU patients.

PIPEDA + PHIPA + Quebec Law 25 (Canada)

Federal privacy law plus provincial health-privacy law: PHIPA in Ontario and Law 25 in Quebec, which requires privacy impact assessments for projects involving personal information. Multi-province work needs jurisdiction handled in the architecture, not just in the consent form.

What the research says about AI projects that stall

In both studies the causes are mostly organizational: unclear problems, missing data, and tools that never fit the workflow. Those are the gaps a readiness score points to.

FAQs about healthcare AI readiness assessments

What is a healthcare AI readiness assessment?
A healthcare AI readiness assessment checks whether a hospital, clinic or life-sciences organization has the prerequisites to run AI in production: usable, PHI-governed clinical data, EHR integration capacity, clinical ownership, change readiness and a compliance posture covering HIPAA, provincial health-privacy law and FDA device rules where they apply. The AIDOLS assessment gives you a 0–100 baseline in about 5 minutes.
How long does the healthcare AI readiness assessment take?
About 5 minutes: 7–8 multiple-choice questions, no signup to start, and an instant 0–100 score with a breakdown across five dimensions (strategy, data, tooling, team and governance). The quiz is the AIDOLS cross-industry assessment; the guide on this page explains what each area means for healthcare specifically.
Does the quiz ask healthcare-specific questions?
No. Every industry page uses the same 7–8-question assessment, so scores are comparable across industries. The questions adapt to your AI maturity (not started, piloting, in production or scaling), and your industry answer shapes the result profile. The healthcare areas, failure patterns and regulations on this page are a checklist to read your score against; the quiz does not audit them.
Does the assessment ask for patient data?
No. The assessment never asks for PHI, patient-level data, financials or system credentials; every question is about your organization at a strategic level. Your answers are kept in your browser. If you choose to email yourself the result, we receive your email address, your first name if you give it, a summary of your answers (company size, industry and AI maturity), your score and result profile, and how you found the page; nothing about patients.
Who in a healthcare organization should take the assessment?
CMIOs, CHIOs, chief digital officers, COOs, VPs of quality and clinical informaticists who need a baseline before asking a board or quality committee for clinical AI budget. In life sciences, it fits CIOs and the leaders running clinical-AI programs.
What does a low score on data or tooling mean in healthcare?
It usually means clinical AI vendors will take far longer to integrate than they quote. The common causes are EHR endpoints that are not FHIR-ready, no system-level relationship with your EHR vendor, and an integration team already at capacity. The right first step is usually an integration-readiness project, not another AI tool.
What happens after I take the healthcare assessment?
You see your 0–100 score, the dimension breakdown, your result profile and three next actions straight away. If you want them by email, enter your address: we send your score and three next steps and reply personally within one business day. If you want to go through it with us, book a 15-minute call: we tell you whether your next step is software, a process change or AI.

Walk through your score in 15 minutes

Once you have your healthcare readiness score, a short call is the fastest way to decide what to fix first. We tell you whether the next step is software, a process change or AI.

Production AI in 90 days. Or you don't pay. For a Build, if the deployed system does not generate ROI exceeding its fee within 90 days, the fee is refunded in full.